Resource utilization associated with extracorporeal membrane oxygenation vs. microaxial flow pump for infarct-related cardiogenic shock
Authors:
- Margriet BogerdMBMargriet Bogerd
- Sanne Ten BergSBSanne Ten Berg
- Elma J PetersEPElma J Peters
- Annemarie E EngströmAEAnnemarie E Engström
- Arjan MalekzadehAMArjan Malekzadeh
- Holger ThieleHTHolger Thiele
- Jacob E MøllerJMJacob E Møller
- Christian HassagerCHChristian Hassager
- Alexander P J VlaarAVAlexander P J Vlaar
- José P S HenriquesJHJosé P S Henriques
Open Access
- 12 February 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 14 (5) , 279-287
Abstract
Aims: Microaxial flow pump and venoarterial extracorporeal membrane oxygenation (VA-ECMO) are increasingly used in infarct-related cardiogenic shock. This study provides a comparative overview of real-world resource utilization associated with these devices (PROSPERO: CRD42024505174). Methods and results: EMBASE, MEDLINE, and Cochrane Library were sought from inception to 13 November 2024 for studies reporting at least one primary outcome, including intensive care unit (ICU) length of stay (LOS), hospital LOS, in-hospital costs, and discharge destination. In-hospital mortality was included as secondary outcome. This study was guided by the PRISMA-2020 guideline. Study selection and data extraction were independently performed by two researchers. Risk-of-bias assessments were done using the Newcastle-Ottawa-Scale. Data were pooled using random-effect models. In total, 12 retrospective cohorts were identified encompassing 92 262 microaxial flow pump- and 16 474 VA-ECMO patients data. The meta-analysis of hospital LOS and in-hospital costs revealed favourable results for the microaxial flow pump, with mean differences (MD) of −5.3 days (95% CI: −6.6, −4.1) and −$113 983 (95% CI: −$143 153, −$84 812), respectively. Microaxial flow pump survivors were also 45% more likely to be discharged home (95% CI: 1.28–1.64). Intensive care unit-length of stay was reported by one study, reporting a 10 days MD in favour of the microaxial flow pump. The averaged in-hospital mortality rates were 44% and 57% for the microaxial flow pump and VA-ECMO, respectively. An inherent limitation of observational studies is confounding by indication. Conclusion: Microaxial flow pump was associated with lower resource utilization compared with VA-ECMO. Resource utilization should be incorporated in prospective RCTs and taken into account when considering these devices.Keywords
This publication has 42 references indexed in Scilit:
- Impella and Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating Acute Myocardial InfarctionEuropean Journal of Heart Failure, 2023
- Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shockAmerican Heart Journal, 2023
- Temporal Trends in Incidence, Causes, Use of Mechanical Circulatory Support and Mortality in Cardiogenic ShockESC Heart Failure, 2021
- Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic ShockJAMA Network Open, 2021
- Impella Versus Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic ShockCardiovascular Revascularization Medicine, 2020
- Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shockCatheterization and Cardiovascular Interventions, 2020
- Incidence and clinical outcomes of stroke in ST‐elevation myocardial infarction and cardiogenic shockCatheterization and Cardiovascular Interventions, 2020
- Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United StatesClinical Research in Cardiology, 2017
- Percutaneous cardiac assist devices compared with surgical hemodynamic support alternativesCatheterization and Cardiovascular Interventions, 2014
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010